Related Experiment Video
Updated: Jun 11, 2025

07:34
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
622
Systematic Biopsy vs. Prostatectomy: Evaluating Correlations and Grading Discrepancies in Prostate Cancer
Andrada Loghin1,2, Maria Cătălina Popelea2, Ioan A Nechifor-Boilă3,4
1Histology, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology of Targu Mures, Târgu Mureș, ROU.
Cureus
|September 30, 2024
Summary
Prostate cancer biopsy accuracy is crucial for prognosis. Tumor length and percentage on biopsy improve grading, but undergrading is common, necessitating repeat biopsies or advanced imaging for precise diagnosis.
Area of Science:
- Uropathology
- Oncology
- Surgical Pathology
Background:
- Prostate cancer (PCa) is a growing global health concern.
- Accurate Gleason Score (GS) from preoperative biopsy is critical for PCa prognosis and patient management.
- Pathological features from biopsy impact treatment strategies.
Purpose of the Study:
- To investigate the correlation between prostate biopsy parameters and prostatectomy specimen pathological features.
- To identify factors contributing to tumor over- and under-grading in biopsy samples.
Main Methods:
- Retrospective study of 110 male patients with confirmed PCa.
- Analysis of biopsy and radical prostatectomy (RP) specimens using standard histopathological techniques.
- Statistical analysis performed using IBM SPSS Statistics.
Main Results:
- Tumoral length on biopsy correlated with positive surgical margin (r=0.289, p<0.01) and tumoral volume (r=0.526, p<0.001) on RP.
- Higher Gleason Grade Groups (GG) on biopsy increased the likelihood of extraprostatic extension (approx. 4x).
- Significant correlation found between Gleason Pattern 4 (%GP4) on biopsy and pT stage (pT4 showed highest %GP4).
- Undergrading occurred significantly more often (30.90%) than overgrading (6.36%) in biopsy samples.
- Greater tumor length and higher tumor percentages in biopsies improved grading accuracy (p<0.001).
Conclusions:
- Systemic biopsies are key predictors of pathological outcomes, with specific parameters serving as prognostic markers.
- The potential for biopsy under- or over-grading highlights the need for careful clinical consideration.
- Repeat biopsies or additional imaging techniques may enhance diagnostic precision for improved treatment strategies.

